Navigation Links
HeartWare to Present at Upcoming Investment Conferences in November
Date:11/6/2009

FRAMINGHAM, Mass. and SYDNEY, Nov. 6 /PRNewswire-FirstCall/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN) a leading innovator and provider of less invasive, miniaturized circulatory support technologies revolutionizing the treatment of advanced heart failure, today announced that it is scheduled to make presentations at two upcoming investor conferences in November.

The first presentation will be made at the Third Annual Canaccord Adams Cardiovascular Conference at 9:00 am PST on Tuesday, November 10. The one-day conference will be held at the Nikko Hotel in San Francisco.

The second presentation will be made at the Lazard Capital Markets Sixth Annual Healthcare Conference at 10:30 am EST on Wednesday, November 18. The conference will be held at the St. Regis Hotel in New York City, November 17-18.

Live webcasts of the Company's presentations at the conferences will be available via a link provided at www.heartware.com. Archived replays of the presentations will also be available shortly after the presentation time for a period of at least 60 days.

About HeartWare International

HeartWare International develops and manufactures miniaturized implantable heart pumps, or left ventricular assist devices, to treat Class IIIb and Class IV patients suffering from advanced heart failure. The HeartWare® Ventricular Assist System features the HVAD(TM) pump, a small full-output circulatory support device (up to 10L/min flow) designed to be implanted next to the heart, avoiding the abdominal surgery generally required to implant competing devices. HeartWare has received CE Marking for the HeartWare® Ventricular Assist System in the European Union. The device is currently the subject of a 150-patient clinical trial in t
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. HeartWare Selects Allen & Caron for Investor Relations and Corporate Communications
2. HeartWare Announces Move to an Expanded, Upgraded Manufacturing Facility
3. HeartWare Receives Conditional Approval of IDE
4. HeartWare to Present at Seventh Annual JMP Securities Research Conference
5. Thoratec Announces Definitive Agreement to Acquire HeartWare International For US$282 Million;
6. Thoratec and HeartWare Receive Request for Additional Information From Federal Trade Commission
7. HeartWare to Present at Eighth Annual JMP Securities Research Conference
8. HeartWare to Webcast Annual Meeting
9. Thoratec Corporation and HeartWare International, Inc. Announce Termination of Proposed Transaction
10. HeartWare International, Inc. Announces US$55 Million Financing
11. HeartWare to Present at Canaccord Adams 29th Annual Global Growth Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...ndfluseasonuponus,it,smoreimportantthanevertoemplo...idillness. ,, "Weneedtobeproactivenotonlytokeep...,resick,"saidEileenFinerty,RN,MS,CIC(certifiedinin...landoccupationalhealthatHospitalforSpecialSurgery(...soneofthelowestinfectionratesofanyhospitalinthecou...
(Date:11/26/2009)... rollercoaster, study finds , , THURSDAY...tor meets the jubilant sports fan. , A new stud... root for the winning team -- enjoy the greatest s...victory was in doubt, producing feelings of worry ...ing weekend as you,re glued to the TV set, watchin...
(Date:11/26/2009)...P.A. is offering free nationwide confidential cons...l pills who have suffered a Deep Vein Thrombosis (...other related cardiac issues or had their Gallblad...-6405 or go to the firm’s website at http:/...luation form. , (PRWEB) N...
(Date:11/25/2009)...MedicalInc.,aleadingmanufacturerofbreastMRIcoilsan...eadingedgeclinicalapplicationsonitsAegis(TM)medica...cietyofNorthAmerica(RSNA)annualmeetinginChicago,No...veragetheuniquehighqualityimagesgeneratedbySentine...magingmodalitiesformulti-parametricassessment. ,...
(Date:11/25/2009)...andPressJoinEfforttoEducate ,, MEMPHIS,Tenn.,N...lBipolarFoundationandtheMedicAlertFoundationreceiv...m,whichisnowbeingwidelyacceptedasapreventivehealth...olarFoundationreceivedaproclamationofendorsementvi...isianaMitchLandrieu.TheNationalBipolarFoundationst...
Breaking Medicine News(10 mins):Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 2Health News:Infection-Control Strategies at Leading Hospital Can be Adapted for Everyday Use 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3
...giverlist.com to Find Quality ...list.com, the nation,s online,destination dedicate...hoices, is helping home care agencies keep up with...and franchise,agencies across the nation including...
...ute of Cardiovascular Disease (GICD) and UCSF have...development of the human vascular system, the ext... that allow blood to reach all tissues and organs.... such as heart disease or cancer, that are impacte...
...ub-Zero Medical receives Governor,s 2008 Excellenc...ecognition of success in international sales; Ohio...ee Fisher present award to CSZ Chairman of the Boa...and the leader in the design and development of ad...
...e men in their 40s has had a prostate specific an... young black men are more likely than young white ...ed in the September 15, 2008 issue of CANCER , a ...ecommendations. , Currently, major medical organi...
... complicated process, as any frustrated dieter mig...te the brain,s intricate neurocircuitry and its ro... a clearer picture of the myriad events that lead ... Center (BIDMC) identifies another piece of this c...
...uting factors to hyperthermia, agency warns , ... aging affects the body,s ability to respond to su...or heat-related illnesses such as heat stroke, hea...ted illnesses include: , Age-related changes to t...
Other Medicine News:Health News:Home Care Agencies Staffing Challenge Solved With Caregiverlist.com 2Health News:Gladstone scientists identify single microRNA that controls blood vessel development 2Health News:Gladstone scientists identify single microRNA that controls blood vessel development 3Health News:State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales 2Health News:State of Ohio Recognizes Cincinnati Sub-Zero for Excellence in International Sales 3Health News:1 in 5 young men has had recent prostate cancer test 2Health News:Scientists identify another piece of the weight-control puzzle 2Health News:More Than Temperature Puts Elderly at Risk in Heat 2
(Date:11/25/2009)..., COLLEGEPARK,Md.,Nov.25/PRNewswire-USNewswire/--...gcream-likefoamthatstopsseverebleeding,wonfirstpri...oftheGlobalSecurityChallenge2009,companyofficialsa...fromaroundtheworld,Remedium,steampitchedtheirinven...nSchoolofBusiness. ,, Remedium( www.remediumtec...
(Date:11/25/2009)..., NEWYORK,Nov.25/PRNewswire/--Reportlinker.comann...catalogue: ,, MammographyEquipment-AGlobalMar...m/p0164330/Mammography-Equipment---A-Global-Market...ncerinindustrializedaswellasdevelopingnationsisapr...et.Globally,escalatingawarenessaboutbreastcancerha...
(Date:11/25/2009)..., CHAPELHILL,N.C.,Nov.25/PRNewswire/--CempraPharm...es,presidentandchiefexecutiveofficer,willpresentat...0a.m.EST,December1,2009,atTheNewYorkPalaceHotelinN...ompany,stwoleadingantibioticclinicalprogramsforthe..., AboutCempraPharmaceuticals ,, Foundedin2...
Breaking Medicine Technology:Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7American Society for Microbiology honors Jo Handelsman 8703 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 1Dr Erika Says Newsweek 26apos 3Bs Attack on Oprah Ignores the Many Benefits of Her Health Care Advocacy 47696 2Media Alert 3A July 10 Run Miles for Special Smiles 47691 1Media Alert 3A July 10 Run Miles for Special Smiles 47691 2
..., Inc. Today,Announced the Top Line Results of the...udy with the Compound Desmoteplase , Aachen (Germa...change, Prime Standard: PA8) and its US partner Fo...d topline results of,the DIAS-2 (Desmoteplase In A...oteplase. The Phase III study was designed to,inve...
...A Plans to Initiate,Phase III Studies in Dry Eye i...-FirstCall/ -- ISTA,Pharmaceuticals, Inc. , today ...alysis of the Company,s Phase IIb clinical study o...atment for dry eye,syndrome. Patients in the ecabe...ctive sign of blink rate. In addition, patients in...
Other Medicine Technology:Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 2Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 3Top Line Results of Phase III Study in Acute Ischemic Stroke,(DIAS-2) Do Not Demonstrate Difference Between Desmoteplase and,Placebo 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 2ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 3ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 4ISTA Pharmaceuticals Announces Positive Preliminary Results from,Ecabet Sodium Phase IIb Study 5
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: